Integrated Multidisciplinary Clinical Care Program
UAB provides an efficient model for cancer care with our innovative Integrated Multidisciplinary Clinical Care Program (IMCCP) for cancer patients. Typically, when you are diagnosed with cancer, your treatment begins with multiple visits to various specialists, which may include a surgical oncologist, medical oncologist, radiation oncologist, pathologist or other therapist. These visits can take eight to 12 weeks, and involve many trips to doctors’ offices, increasing the stress associated with your cancer treatment.
But with UAB’s IMCCP, all of those visits are combined into one, and you leave that day with a clear treatment plan to fight your cancer. A site-specific patient care coordinator will contact you prior to your visit to ensure all your preliminary testing has been done, and will assemble all medical records. This patient care coordinator will guide you through your day, escorting you to each appointment, eliminating much of the stress involved with seeing multiple physicians in one day.
In addition, our physicians integrate traditional cancer treatment with opportunities to participate in clinical trials for patients who are eligible.
UAB’s IMCCP is currently available for gynecologic oncology, leukemia and lymphoma, otolaryngology, breast and gastrointestinal cancer.
But with UAB’s IMCCP, all of those visits are combined into one, and you leave that day with a clear treatment plan to fight your cancer. A site-specific patient care coordinator will contact you prior to your visit to ensure all your preliminary testing has been done, and will assemble all medical records. This patient care coordinator will guide you through your day, escorting you to each appointment, eliminating much of the stress involved with seeing multiple physicians in one day.
In addition, our physicians integrate traditional cancer treatment with opportunities to participate in clinical trials for patients who are eligible.
UAB’s IMCCP is currently available for gynecologic oncology, leukemia and lymphoma, otolaryngology, breast and gastrointestinal cancer.
